LuciDabra 75mg (Dabrafenib)

Description

LuciDabra 75mg (Dabrafenib) is a targeted cancer treatment used for patients with cancers that carry a BRAF V600 mutation. Doctors commonly prescribe LuciDabra 75mg for conditions such as melanoma, non-small cell lung cancer (NSCLC), and anaplastic thyroid cancer.

Dosage:

The usual adult dose of LuciDabra 75mg (Dabrafenib) is 150 mg twice daily (two 75 mg capsules each time), taken on an empty stomach or as directed by a healthcare professional. It is often used with trametinib to improve treatment results.

Side Effects

Some patients using LuciDabra 75mg (Dabrafenib) may experience:

• Fever
• Fatigue
• Headache
• Nausea
• Skin rash
• Joint pain

In rare cases, LuciDabra 75mg may cause serious side effects such as heart, eye, or severe skin reactions. Patients should consult a doctor if unusual symptoms appear.

Prescribing Information

Before starting treatment, doctors usually confirm the BRAF V600 mutation through diagnostic testing. LuciDabra 75mg (Dabrafenib) should only be used under the supervision of an experienced healthcare professional.

Patients should inform their doctor about other medications and avoid using LuciDabra 75mg during pregnancy or breastfeeding.

Suggestion

For best results, take LuciDabra 75mg (Dabrafenib) exactly as prescribed. Do not change the dose or stop treatment without medical advice. Regular monitoring during treatment is recommended.

FAQ

What is LuciDabra 75mg (Dabrafenib) used for?
It is used to treat cancers with a BRAF V600 mutation, including melanoma and lung cancer.

How does LuciDabra 75mg work?
LuciDabra 75mg (Dabrafenib) blocks the abnormal BRAF protein, helping slow the growth of cancer cells.

How should LuciDabra 75mg be taken?
It is usually taken twice daily on an empty stomach, as prescribed by a doctor.